Details of the Drug
General Information of Drug (ID: DMEFP15)
Drug Name |
1-(1-Benzo[b]thiophen-2-yl-cyclohexyl)-azepane
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL17945; 1-[1-(1-benzothiophen-2-yl)cyclohexyl]azepane; NCI60_038332; AC1L9GGF; 1-(1-Benzo[b]thiophen-2-yl-cyclohexyl)-azepane; CTK5J7197; QDGRJLAJZNWVGV-UHFFFAOYSA-N; BDBM50040192; 1-[1-(1-Benzothien-2-yl)cyclohexyl]azepane #; Thionaphthene, 2-[1-(1-azacycloheptyl)cyclohexyl]-
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 313.5 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 5.6 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References